Nutraplus India (BOM:524764) OCF Yield %: -5.52 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nutraplus India OCF Yield %?

Nutraplus India BOM:524764 OCF Yield % is -5.52 as of Jul. 18, 2026. The stock has 1 warning sign investors should review.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Nutraplus India's Trailing 12-Month Cash Flow from Operations is ₹0.00 Mil, and Market Cap is ₹71.59 Mil. Therefore, Nutraplus India's OCF Yield % for today is -5.52%.

The historical rank and industry rank for Nutraplus India's OCF Yield % or its related term are showing as below:

BOM:524764' s OCF Yield % Range Over the Past 10 Years
Min: -5.52   Med: 0   Max: -5.52
Current: -5.52


During the past 13 years, the highest OCF Yield % of Nutraplus India was -5.52%. The lowest was -5.52%. And the median was %.

BOM:524764's OCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.55 vs BOM:524764: -5.52

Nutraplus India's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Nutraplus India OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nutraplus India OCF Yield % Related Terms


Nutraplus India OCF Yield % Historical Data

* Premium members only.

The historical data trend for Nutraplus India's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutraplus India OCF Yield % Chart

Nutraplus India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.42 0.23 -0.11 0.00 -5.52

Nutraplus India Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524764 vs ZTS: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nutraplus India's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutraplus India OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nutraplus India's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Nutraplus India's OCF Yield % falls into.



Nutraplus India OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Nutraplus India's OCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-3.95 / 71.5911
=-5.52%

Nutraplus India's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 71.5911
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -5.52 mean?
Nutraplus India (BOM:524764) has a OCF Yield % of -5.52 as of Jul. 18, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nutraplus India and its competitors.
Is Nutraplus India's OCF Yield % too high?
Nutraplus India's current OCF Yield % is -5.52.
How does Nutraplus India's OCF Yield % compare to ZTS?
Nutraplus India's OCF Yield % of -5.52 can be compared against companies in the Drug Manufacturers industry. The industry median OCF Yield % is 3.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.55, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nutraplus India and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutraplus India's current OCF Yield % is -5.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutraplus India stock overvalued right now?
Nutraplus India (BOM:524764) has a current OCF Yield % of -5.52. The current OCF Yield % is -5.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Nutraplus India (BOM:524764), the current OCF Yield % is -5.52 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nutraplus India Business Description

Address Subhash Road, 326-A, Pioneer Industrial Estate, Pioneer Eyelets Mfg. Co. Ltd., Jogeshwari (East), Mumbai, MH, IND, 400060
Nutraplus India Ltd is an India based company engaged in manufacturing of active pharmaceutical ingredients (API), intermediates and contract manufacturing of intermediates. It produces bulk drugs, and specialty chemicals and intermediates. The company's product portfolio encompasses therapeutic categories like analgesic, anti-asthma, antimalarial, anti-protozoan infections, mucolyting agent, and antihelmintic.